LifeStance Health Group's Q3 Earnings Soar 29.94%, Boosting Stock Price 30%.

LifeStance Health Group (LFST) reported a 29.94% increase in its stock price to $6.25 per share after announcing impressive Q3 earnings, with a net income of $1.077 million and a 16% increase in total revenues to $363.8 million. The company also raised its full-year adjusted EBITDA guidance to a range of $146 million to $152 million and projected Q4 revenues of $368 million to $388 million.